Results 101 to 110 of about 5,275 (178)

Gout Remission With Pegloticase-Induced Intensive Urate-Lowering Therapy: A Post Hoc Clinical Trial Analysis. [PDF]

ACR Open Rheumatol
Klionsky Y, Torralba KD, Obermeyer K, Padnick-Silver L, Lam G, LaMoreaux B.   +5 more
europepmc   +1 more source

Combination of sodium-glucose cotransporter type 2 inhibitors and urate-lowering therapy in people with gout from a specialist clinic: a retrospective, single-center observational study. [PDF]

Front Med (Lausanne)
Doménech-Serrano J, García-Loiseau I, Rodríguez-Alvear C, Riesgo-Sanchis P, Moreno-Pérez Ó, Andrés M.   +5 more
europepmc   +1 more source

Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout. [PDF]

BMC Med Inform Decis Mak, 2022
Te Kampe R, Boonen A, Jansen TL, Elling JM, Flendrie M, van Eijk-Hustings Y, Janssen M, van Durme C, de Vries H.   +8 more
europepmc   +1 more source

Outcomes in Patients With Multiple Myeloma and Prescribed Urate-Lowering Therapy: A Propensity-Matched Study. [PDF]

Cureus
Eidbo S, Barnett M, Lema Rodriguez D, Tsibadze N, Pappas A, Shah M, Shah A, Mayo R.   +7 more
europepmc   +1 more source

Pacific community's perceptions on how to improve uptake of urate-lowering therapy for Pacific gout patients. [PDF]

Int J Equity Health
Ofanoa S, Ofanoa M, Tu'akoi S, Lutui H, Heather M, Goodyear-Smith F.   +5 more
europepmc   +1 more source

Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout. [PDF]

Int J Med Sci, 2021
Yen FS, Wei JC, Chang CL, Yang CC, Hsu CC, Hwu CM.   +5 more
europepmc   +1 more source

Firsekibart as a Prophylactic Treatment for Acute Gout Flare in Participants Initiating Urate-Lowering Therapy: A Phase 2, Randomized, Open-Label, Multicenter, Active-Controlled Trial. [PDF]

ACR Open Rheumatol
Yu Y, Xue Y, Hu J, Zhang N, Li R, Guo H, Qian L, Gou W, Yang J, Mao L, Yu J, Liu S, Xu Q, Luo T, Zou H.   +14 more
europepmc   +1 more source

Oral Urate-Lowering Therapy Use and Efficacy Following Pegloticase Treatment: Findings from a Rheumatology Network Database. [PDF]

Rheumatol Ther
Padnick-Silver L, Concoff A, Gao HY, Fu Q, LaMoreaux B, Edwards NL.   +5 more
europepmc   +1 more source

Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis. [PDF]

Ther Adv Musculoskelet Dis, 2021
Sharma G, Dubey A, Nolkha N, Singh JA.
europepmc   +1 more source

A single-centre experience of febuxostat as a second-line urate-lowering therapy. [PDF]

Malays Fam Physician, 2021
Ong SG, Ding HJ.
europepmc   +1 more source